Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study)

Tocilizumab, a humanized monoclonal antibody to the interleukin 6 (IL-6) receptor, was approved for use as rheumatoid arthritis (RA) therapy in Japan in 2008, but its efficacy and tolerability in daily practice has not yet been reported. We report the results of a multicenter retrospective study on...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamanaka, Hisashi, Tanaka, Yoshiya, Inoue, Eisuke, Hoshi, Daisuke, Momohara, Shigeki, Hanami, Kentaro, Yunoue, Naoki, Saito, Kazuyoshi, Amano, Kouichi, Kameda, Hideto, Takeuchi, Tsutomu
Formato: Texto
Lenguaje:English
Publicado: Springer Japan 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071926/
https://www.ncbi.nlm.nih.gov/pubmed/20953815
http://dx.doi.org/10.1007/s10165-010-0366-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071926/
https://www.ncbi.nlm.nih.gov/pubmed/20953815
http://dx.doi.org/10.1007/s10165-010-0366-7

Ejemplares similares